ACLS three-lens brief
Evidence-based stock research on ACLS. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Analyst mean target $161.00 — 42% above current (3 analysts). · Trading >3% below the 50-day MA — short-term weakness.
- Trading >3% below the 50-day MA — short-term weakness.
- Analyst mean target $161.00 — 42% above current (3 analysts).
ACLS closed at $113.30 (-1.96%) as of 2026-09-11. Market cap: $3.50B. P/E (trailing) 38.8. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $161.00 — 42% above current (3 analysts).. Concerns: trading >3% below the 50-day MA — short-term weakness.. Last quarter: Revenue $215.18M, net income $23.29M, free cash flow $42.03M.
Why three lenses on ACLS, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ACLSacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ACLS" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ACLS brief"></iframe>